Fetzima

Levomilnacipran Hydrochloride

4.9 Moderate risk

Fetzima & Off label use

20.2%

of users reported Off label use

88.9%

also reported Severe reaction

70.5%

are women

Most common medical consequences

Severe reaction

88.9%

Hospitalization

11.1%

Have you experienced any negative side effects from this medication?

Fetzima: general information

Most common side effects (20)

Most commonly affected ages

10 - 19 years

3.5%

20 - 29 years

<0.1%

30 - 39 years

11.9%

40 - 49 years

28.3%

50 - 59 years

34.3%

60 - 69 years

16.8%

70 - 79 years

5.2%